# Maxona Pharmaceuticals, Inc. — Form D

Maxona Pharmaceuticals, Inc. of Malvern, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-13. The offering totals $5.0M, of which $900K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-06-13
- Form: D
- Accession: 0001857448-25-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $900K
- Remaining: $4.1M
- Investors: 15
- Date of first sale: 2025-06-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-548944

## Issuer

- Name: Maxona Pharmaceuticals, Inc.
- CIK: 0001857448
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 101 Lindenwood Drive, Malvern, PA, 19355
- Phone: 484.681.5626

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Shahin Fatholahi | Director | Malvern, PA |
| David Nakamura | Director | Malvern, PA |
| Behshad Sheldon | Director | Malvern, PA |
| Richard Brand | Executive Officer | Malvern, PA |
| Shahin Fatholahi | Executive Officer | Malvern, PA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-05-05](https://search.stillhousedata.com/formd/0001857448-21-000001) | D | $10.0M | $5.6M |

## More

- [CIK 1857448 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1857448&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001857448-25-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.